Mucinex® ER 600 mg Bi-layer Tablet Versus Guaifenesin Immediate Release (IR) 200 mg q4h

NCT03642262 PHASE1 COMPLETED Results posted

Demonstrate bioequivalence of guaifenesin in Mucinex® extended release (ER) 600 mg tablet in normal healthy volunteers compared to the immediate release guaifenesin 200 mg tablet reference product marketed

Details

Lead sponsor	Reckitt Benckiser Inc.
Phase	PHASE1
Status	COMPLETED
Enrolment	30
Start date	Sun Jun 02 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Fri Aug 09 2013 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Healthy Subjects

Interventions

• Mucinex®